Joymed is a leading one-stop medical device CDMO technology platform in China. Focusing on the field of drug delivery, it boasts full-chain service capabilities covering conceptual design, R&D verification, large-scale mass production and global compliance registration in drug delivery device technology platforms and autoinjectors (including electronic smart injectors). It provides customized overall drug delivery and injection solutions for pharmaceutical and medical device enterprises worldwide.
The core engineers of the company’s R&D team all have over 15 years of industry experience. Joymed has built a full-professional technical system covering electronics, structural design, software, materials and precision testing, and masters core technologies such as high-precision drug delivery control and intelligent air venting algorithms. The self-developed electronic injector can control the drug delivery error within ±0.005ml, and supports innovative functions including automatic priming, multi-specification adaptation and reusable design, balancing precision, safety and compliance.
On the production side, Joymed has globally deployed manufacturing bases in China, Malaysia and other regions. It is equipped with Class 10,000 / Class 100,000 GMP clean workshops, precision injection molding and assembly production lines, as well as automatic testing equipment, and has established a complete traceability system to ensure the stability and compliance of mass production. Meanwhile, it maintains a robust quality and regulatory system certified to ISO 13485, and offers global registration services including NMPA, CE and FDA certification.
Leveraging its modular intelligent manufacturing system, Joymed can rapidly respond to customers’ customized demands and provide full-process CDMO services from early-stage R&D, design transfer and process development to commercial mass production. It caters to autoinjector demands across multiple sectors such as growth hormone, insulin and biological preparations, empowering the upgrading of the global drug delivery industry with the strength of "Intelligent Manufacturing in China".
